Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer

NCT06959550 PHASE2 RECRUITING

The goal of this clinical research study is to learn if ivonescimab can help to control previously treated, metastatic colorectal cancer.

Details

Lead sponsor	M.D. Anderson Cancer Center
Phase	PHASE2
Status	RECRUITING
Enrolment	90
Start date	Mon Jul 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Metastatic Colorectal Cancer

Interventions

• Ivonescimab

Countries

United States